• $656,419.00
    Market Cap
  • 9,900.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
08/31/2021
08/31/2020
Income Statement
Total Operating Revenue
1.6M
+5,828.89%
27,004
N/A
Cost of Revenue
1.4M
+5,677.82%
24,521
N/A
Gross Profit
184,258
+7,320.78%
2,483
N/A
Sales and Marketing Expense
64,667
-69.68%
213,302
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
45,482
+1,260.92%
3,342
N/A
Total Operating Expenses
2.1M
-41.31%
3.6M
N/A
Operating Profit
-1.9M
-46.36%
-3.6M
N/A
Interest Income
-55,435
N/A
N/A
N/A
Interest Expense
-7.4M
+422.85%
-1.4M
N/A
Interest Income and Expense and Net
-7.5M
+426.74%
-1.4M
N/A
Total Nonoperating Income and Expense
-6.2M
+372.79%
-1.3M
N/A
Income before Taxes
-1.9M
-46.36%
-3.6M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
0
N/A
Net Income
-7.8M
+58.94%
-4.9M
N/A
Net Income from Continuing Operations Applicable to Common
-7.8M
+58.94%
-4.9M
N/A
Basic EPS and Net Income
-0.13
-55.17%
-0.29
N/A
Diluted EPS and Net Income
-0.13
-55.17%
-0.29
N/A
Basic Weighted Average Shares
58.3M
+240.84%
17.1M
N/A
Diluted Weighted Average Shares
58.3M
+240.84%
17.1M
N/A
Balance Sheet
Cash and Cash Equivalents
30,813
+1,217.92%
2,338
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
30,813
+1,217.92%
2,338
N/A
Total Current Assets
442,065
+469.11%
77,676
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
218,535
+760.17%
25,406
N/A
Total Long-Term Assets
218,535
+760.17%
25,406
N/A
Total Assets
11.3M
+387.65%
2.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.7M
+13.96%
2.4M
N/A
Total Current Liabilities
8.7M
+132.61%
3.8M
N/A
Total Long-Term Debt
672,794
+1,245.59%
50,000
N/A
Total Long-Term Liabilities
1.2M
+9.77%
1.1M
N/A
Total Liabilities
10.0M
+165.47%
3.8M
N/A
Retained Earnings
-13.9M
+129.35%
-6.1M
N/A
Total Stockholders Equity
-2.2M
+54.14%
-1.4M
N/A
Total Shares Outstanding
84.9M
+213.64%
27.1M
N/A
Cash Flow
Cash from Operating Activities
-1.5M
-3.36%
-1.5M
N/A
Capital Expenditures
9,511
-38.63%
15,499
N/A
Cash from Investing Activities
-7,311
-52.83%
-15,499
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.5M
+8.57%
1.4M
N/A
Financials Ratio
Gross Margin
11.51%
+25.16%
9.19%
N/A
Operating Margin
-121.42%
-99.10%
-13,419.83%
N/A
Return on Assets
-114.68%
-70.45%
-388.14%
N/A
Return on Equity
429.59%
-40.13%
717.59%
N/A
Revenue Growth
5,828.89%
N/A
N/A
N/A
Current Ratio
0.05
+143.96%
0.02
N/A
Cash Ratio
0.004
+483.33%
0.0006
N/A
Debt-to-Equity Ratio
-1.52
-9.54%
-1.68
N/A
Debt-to-Assets Ratio
0.30
-71.41%
1.04
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow